Laselipag
CAS 475085-57-5
MF C25H29N3O3 MW 419.52
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]acetic acid
{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid
prostanoid receptor agonist, ACT-333679, ACT 333679, ACT333679, E9PC7N0DID, MRE 269
ACT-333679 is a member of the class of pyrazines that is {4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetic acid carrying two additional phenyl substituents at positions 5 and 6 on the pyrazine ring. The active metabolite of selexipag, an orphan drug used for the treatment of pulmonary arterial hypertension. It has a role as an orphan drug, a platelet aggregation inhibitor, a prostacyclin receptor agonist, a vasodilator agent and a drug metabolite. It is an aromatic amine, an ether, a member of pyrazines, a sulfonamide, a tertiary amino compound and a monocarboxylic acid.
SYN
SYN
PAT
- Heterocyclic compound derivatives and medicinesPublication Number: CA-2445344-CPriority Date: 2001-04-26Grant Date: 2011-07-26
- Heterocyclic compound derivatives and medicinesPublication Number: US-2004102436-A1Priority Date: 2001-04-26
- DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTSPublication Number: DE-60217674-T2Priority Date: 2001-04-26Grant Date: 2007-10-11
- Heterocyclic compound derivatives and medicinesPublication Number: EP-1400518-B1Priority Date: 2001-04-26Grant Date: 2007-01-17
- Heterocyclic compound derivatives and medicinesPublication Number: US-7205302-B2Priority Date: 2001-04-26Grant Date: 2007-04-17
- Heterocyclic compound derivatives and medicinesPublication Number: CA-2445344-A1Priority Date: 2001-04-26
- Heterocyclic derivatives and pharmaceuticalsPublication Number: JP-4479152-B2Priority Date: 2001-04-26Grant Date: 2010-06-09
- DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINESPublication Number: RU-2003134190-APriority Date: 2001-04-26
- DERIVATIVES OF HETEROCYCLIC COMPOUNDS AND MEDICINAL PRODUCTS CONTAINING THEMPublication Number: PT-1400518-EPriority Date: 2001-04-26
- Heterocyclic compound derivatives and medicinesPublication Number: EP-1400518-A1Priority Date: 2001-04-26
- DERIVATIVES OF HETEROCICLIC COMPOUNDS AND MEDICINES.Publication Number: ES-2276931-T3Priority Date: 2001-04-26Grant Date: 2007-07-01
AS ON OCT2025 4.511 LAKHS VIEWS ON BLOG WORLDREACH AVAILABLEFOR YOUR ADVERTISEMENT
join me on Linkedin
Anthony Melvin Crasto Ph.D – India | LinkedIn
join me on Researchgate
RESEARCHGATE
join me on Facebook
Anthony Melvin Crasto Dr. | Facebook
join me on twitter
Anthony Melvin Crasto Dr. | twitter
+919321316780 call whatsaapp
EMAIL. amcrasto@gmail.com
......
//////laselipag, prostanoid receptor agonist, ACT-333679, ACT 333679, ACT333679, E9PC7N0DID, MRE 269
#laselipag, #prostanoid receptor agonist, #ACT-333679, #ACT 333679, #ACT333679, #E9PC7N0DID, #MRE 269
No comments:
Post a Comment